LicianPro

MANGOCEUTICALS, INC. ·

MGRX 8-K 2026-10-01

MANGOCEUTICALS, INC. (MGRX) 8-K dated 2026-10-01 — accession 0001493152-26-045341.

MANGOCEUTICALS, INC. (MGRX) is a health information services company listed on US.

MANGOCEUTICALS, INC. filed a 8-K on 2026-10-01. Accession 0001493152-26-045341.

This 8-K covers: Material agreement (Item 1.01), Acquisition or disposition (Item 2.01), Unregistered share sale (Item 3.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported MGRX revenue for 2025-12-31 was $456.0K. Net income was -$20.6M. Revenue was down 26.0% from 2024-12-31 to 2025-12-31. MGRX currently screens at market cap $16.3M.

Not investment advice. The MGRX SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr